Pfizer-BioNTech's COVID-19 Vaccine Third Dose More Effective in Reducing Severe Coronavirus Illness: Lancet : vimarsana.com

Pfizer-BioNTech's COVID-19 Vaccine Third Dose More Effective in Reducing Severe Coronavirus Illness: Lancet

The results show that, compared with individuals who received only two doses five months prior, individuals who received three doses of the vaccine (7 days or more after the third dose) had 92 per cent lower risk of severe Covid-19 disease and 81 per cent lower risk of Covid-19-related death. 🍏 Pfizer-BioNTech’s COVID-19 Vaccine Third Dose More Effective in Reducing Severe Coronavirus Illness: Lancet.

Related Keywords

Jerusalem , Israel General , Israel , India , , Pfizer , Clalit Research Institute , Ran Balicer , People With Weaker Immune , Coverage Exceeds , Bnt162b2 Vaccine , Coronavirus Illness , Covid19 Vaccine , Covid19 Vaccine Dose , Lancet ,

© 2024 Vimarsana